Cargando…

Radiation Treatment for WHO Grade II and III Meningiomas

The treatment of meningiomas is tailored to their histological grade. While World Health Organization (WHO) grade I lesions can be treated with either surgery or external beam radiation, WHO Grade II and III lesions often require a combination of the two modalities. For these high-grade lesions, con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walcott, Brian P., Nahed, Brian V., Brastianos, Priscilla K., Loeffler, Jay S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759290/ https://www.ncbi.nlm.nih.gov/pubmed/24032107 http://dx.doi.org/10.3389/fonc.2013.00227

Ejemplares similares

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma
por: Hua, Lingyang, et al.
Publicado: (2020)

Analysis of Prognostic Factors of World Health Organization Grade Ⅲ Meningiomas
por: Tian, Weidong, et al.
Publicado: (2020)

Development and Validation of Prognostic Nomogram in Patients With WHO Grade III Meningioma: A Retrospective Cohort Study Based on SEER Database
por: Jia, Zetian, et al.
Publicado: (2021)

Mitotic and Proliferative Indices in WHO Grade III Meningioma
por: Daniela Maier, Andrea, et al.
Publicado: (2020)

The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion
por: Jiang, Jun, et al.
Publicado: (2023)

Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review
por: Kannapadi, Nivedha V., et al.
Publicado: (2022)

Intracranial Grade II Meningioma Oligometastatic to the Cervical Spine
por: Natarajan, Jyotsna M, et al.
Publicado: (2021)

A Clinical Prognostic Model Based on Preoperative Hematological and Clinical Parameters Predicts the Progression of Primary WHO Grade II Meningioma
por: Gao, Peng, et al.
Publicado: (2021)

Emerging systemic treatment options in meningioma
por: Mair, Maximilian J., et al.
Publicado: (2022)

A Clinical Semantic and Radiomics Nomogram for Predicting Brain Invasion in WHO Grade II Meningioma Based on Tumor and Tumor-to-Brain Interface Features
por: Li, Ning, et al.
Publicado: (2021)

MNG-03 PD-L1 EXPRESSION, PATIENT PROGNOSIS AND INITIAL WHO GRADE IN GRADE II/III MENINGIOMA
por: Kamamoto, Dai, et al.
Publicado: (2019)

Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas
por: González-Tablas, María, et al.
Publicado: (2021)

The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series
por: Roehrkasse, Amanda M., et al.
Publicado: (2022)

TERT promoter mutations in primary and secondary WHO grade III meningioma
por: Maier, Andrea Daniela, et al.
Publicado: (2020)

Specific gene expression signatures of low grade meningiomas
por: Tsitsikov, Erdyni N., et al.
Publicado: (2023)

WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index
por: Haddad, Alexander F., et al.
Publicado: (2020)

Recurrence/Regrowth in Grade I Meningioma: How to Predict?
por: de Carvalho, Gervásio Teles Cardoso, et al.
Publicado: (2020)

Genetic Characterization of Brain Metastases in the Era of Targeted Therapy
por: Han, Catherine H., et al.
Publicado: (2017)

Targeting Molecular Pathways in Intracranial Metastatic Disease
por: Venur, Vyshak Alva, et al.
Publicado: (2019)

Histological transformation in recurrent WHO grade I meningiomas
por: Corniola, Marco V., et al.
Publicado: (2020)

Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas
por: Brastianos, Priscilla K., et al.
Publicado: (2022)

Metastatic meningioma: Case report of a WHO grade I meningioma with liver metastases and review of the literature
por: Beutler, Bryce D., et al.
Publicado: (2019)

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma
por: Wang, Daijun, et al.
Publicado: (2020)

Gene Expression Signatures Identify Biologically Homogenous Subgroups of Grade 2 Meningiomas
por: Zador, Zsolt, et al.
Publicado: (2020)

Surgical Outcome of Treating Grades II and III Meningiomas: A Report of 32 Cases
por: Violaris, Konstantinos, et al.
Publicado: (2013)

Predicting the grade of meningiomas by clinical–radiological features: A comparison of precontrast and postcontrast MRI
por: Yao, Yuan, et al.
Publicado: (2022)

Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas
por: Weber, Lorenz, et al.
Publicado: (2022)

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy
por: Steidl, Eike, et al.
Publicado: (2021)

Preoperative Radiomics Analysis of 1p/19q Status in WHO Grade II Gliomas
por: Fan, Ziwen, et al.
Publicado: (2021)

Clinicopathologic Characteristics of Grade 2/3 Meningiomas: A Perspective on the Role of Next-Generation Sequencing
por: Kim, Junhyung, et al.
Publicado: (2022)

Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
por: Williams, Erik A., et al.
Publicado: (2020)

CDK 4/6 inhibitors for the treatment of meningioma
por: Young, Jacob S., et al.
Publicado: (2022)

Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2016)

Case of a WHO Grade II Atypical Meningioma in a 16-Year-Old Female
por: Khan, Mahad A, et al.
Publicado: (2023)

World Health Organization meningioma grade II
por: Parkhi, Rutuja Bhaskar, et al.
Publicado: (2022)

Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma
por: Wiestler, Benedikt, et al.
Publicado: (2016)

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy
por: Deng, Jiaojiao, et al.
Publicado: (2021)

Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients
por: Bernatz, Simon, et al.
Publicado: (2021)

Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
por: Juratli, Tareq A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cehrud8hnatb139s8e1ig887nb